Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells

被引:99
作者
Wei, Ping [1 ,2 ]
Wong, Wilson W. [1 ,2 ,3 ]
Park, Jason S. [1 ,2 ,3 ]
Corcoran, Ethan E. [2 ,3 ,4 ]
Peisajovich, Sergio G. [1 ,2 ]
Onuffer, James J. [1 ,3 ]
Weiss, Arthur [2 ,3 ,4 ]
Lim, Wendell A. [1 ,2 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Cell Prop Lab, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; T-CELLS; PHOSPHOTHREONINE LYASE; TYROSINE-PHOSPHATASE; SYNTHETIC BIOLOGY; GENE-EXPRESSION; ADVERSE EVENT; ACTIVATION; YERSINIA; ADAPTATION;
D O I
10.1038/nature11259
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bacterial pathogens have evolved specific effector proteins that, by interfacing with host kinase signalling pathways, provide a mechanism to evade immune responses during infection(1,2). Although these effectors contribute to pathogen virulence, we realized that they might also serve as valuable synthetic biology reagents for engineering cellular behaviour. Here we exploit two effector proteins, the Shigella flexneri OspF protein(3) and Yersinia pestis YopH protein(4), to rewire kinase-mediated responses systematically both in yeast and mammalian immune cells. Bacterial effector proteins can be directed to inhibit specific mitogen-activated protein kinase pathways selectively in yeast by artificially targeting them to pathway-specific complexes. Moreover, we show that unique properties of the effectors generate new pathway behaviours: OspF, which irreversibly inactivates mitogen-activated protein kinases(4), was used to construct a synthetic feedback circuit that shows novel frequency-dependent input filtering. Finally, we show that effectors can be used in T cells, either as feedback modulators to tune the T-cell response amplitude precisely, or as an inducible pause switch that can temporarily disable T-cell activation. These studies demonstrate how pathogens could provide a rich toolkit of parts to engineer cells for therapeutic or biotechnological applications.
引用
收藏
页码:384 / +
页数:7
相关论文
共 32 条
  • [1] An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses
    Arbibe, Laurence
    Kim, Dong Wook
    Batsche, Eric
    Pedron, Thierry
    Mateescu, Bogdan
    Muchardt, Christian
    Parsot, Claude
    Sansonetti, Philippe J.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (01) : 47 - 56
  • [2] Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics
    Bashor, Caleb J.
    Helman, Noah C.
    Yan, Shude
    Lim, Wendell A.
    [J]. SCIENCE, 2008, 319 (5869) : 1539 - 1543
  • [3] The suicide gene therapy challenge: How to improve a successful gene therapy approach
    Bonini, Chiara
    Bondanza, Attilio
    Perna, Serena Kimi
    Kaneko, Shin
    Traversari, Catia
    Ciceri, Fabio
    Bordignon, Claudio
    [J]. MOLECULAR THERAPY, 2007, 15 (07) : 1248 - 1252
  • [4] Feedback loops shape cellular signals in space and time
    Brandman, Onn
    Meyer, Tobias
    [J]. SCIENCE, 2008, 322 (5900) : 390 - 395
  • [5] Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial
    Brentjens, Renier
    Yeh, Raymond
    Bernal, Yvette
    Riviere, Isabelle
    Sadelain, Michel
    [J]. MOLECULAR THERAPY, 2010, 18 (04) : 666 - 668
  • [6] Tipping the balance by manipulating post-translational modifications
    Broberg, Christopher A.
    Orth, Kim
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2010, 13 (01) : 34 - 40
  • [7] Frequency-modulated nuclear localization bursts coordinate gene regulation
    Cai, Long
    Dalal, Chiraj K.
    Elowitz, Michael B.
    [J]. NATURE, 2008, 455 (7212) : 485 - U16
  • [8] Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
    Ciceri, Fabio
    Bonini, Chiara
    Stanghellini, Maria Teresa Lupo
    Bondanza, Attilio
    Traversari, Catia
    Salomoni, Monica
    Turchetto, Lucia
    Colombi, Scialini
    Bernardi, Massimo
    Peccatori, Jacopo
    Pescarollo, Alessandra
    Servida, Paolo
    Magnani, Zulma
    Perna, Serena K.
    Valtolina, Veronica
    Crippa, Fulvio
    Callegaro, Luciano
    Spoldi, Elena
    Crocchiolo, Roberto
    Fleischhauer, Katharina
    Ponzoni, Maurilio
    Vago, Luca
    Rossini, Silvano
    Santoro, Armando
    Todisco, Elisabetta
    Apperley, Jane
    Olavarria, Eduardo
    Slavin, Shimon
    Weissinger, Eva M.
    Ganser, Arnold
    Stadler, Michael
    Yannaki, Evangelia
    Fassas, Athanasios
    Anagnostopoulos, Achilles
    Bregni, Marco
    Stampino, Corrado Gallo
    Bruzzi, Paolo
    Bordignon, Claudio
    [J]. LANCET ONCOLOGY, 2009, 10 (05) : 489 - 500
  • [9] An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease
    de Witte, Moniek A.
    Jorritsma, Annelies
    Swart, Erwin
    Straathof, Karin C.
    de Punder, Karin
    Haanen, John B. A. G.
    Rooney, Cliona M.
    Schumacher, Ton N. M.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (09) : 6365 - 6373
  • [10] MAP kinases in the immune response
    Dong, C
    Davis, RJ
    Flavell, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 55 - 72